Prothena Updates Corporate Address & Contact Info in 8-K Filing
Ticker: PRTA · Form: 8-K · Filed: Jan 8, 2024 · CIK: 1559053
| Field | Detail |
|---|---|
| Company | Prothena Corp Public Ltd Co (PRTA) |
| Form Type | 8-K |
| Filed Date | Jan 8, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01, $621 million |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: corporate-update, administrative, contact-info
TL;DR
**Prothena filed an 8-K updating its official business address and phone number.**
AI Summary
Prothena Corporation Public Limited Company filed an 8-K on January 8, 2024, to update its corporate information, specifically its address and contact details. The filing indicates a change in the company's principal executive offices to 77 Sir John Rogerson’s Quay, Block C, Grand Canal Docklands, Dublin 2, D02 VK60, Ireland, with a telephone number of 011-353-1-236-2500. This matters to investors because it provides current and accurate contact information for the company, which is essential for any shareholder communications or due diligence.
Why It Matters
This filing provides updated official contact information for Prothena, ensuring investors and regulators have the correct details for communication and compliance.
Risk Assessment
Risk Level: low — This filing is purely administrative, updating contact information, and does not indicate any operational or financial risks.
Analyst Insight
Investors should update their records with Prothena's new contact information, but this filing itself does not warrant any immediate trading action as it's purely administrative.
Key Players & Entities
- PROTHENA CORP PUBLIC LTD CO (company) — the registrant filing the 8-K
- 77 Sir John Rogerson’s Quay, Block C, Grand Canal Docklands, Dublin 2, D02 VK60, Ireland (location) — the new principal executive offices address
- 011-353-1-236-2500 (number) — the new business telephone number
- January 8, 2024 (date) — the date of the earliest event reported
FAQ
What is the purpose of Prothena's 8-K filing on January 8, 2024?
The purpose of Prothena's 8-K filing on January 8, 2024, is to report current events, specifically updating its principal executive offices address and telephone number, under Item Information: Other Events.
What is the new principal executive office address for Prothena Corporation Public Limited Company?
The new principal executive office address for Prothena Corporation Public Limited Company is 77 Sir John Rogerson’s Quay, Block C, Grand Canal Docklands, Dublin 2, D02 VK60, Ireland.
What is the updated business telephone number for Prothena?
The updated business telephone number for Prothena Corporation Public Limited Company is 011-353-1-236-2500.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on January 8, 2024.
Under which items of Form 8-K was this filing made?
This filing was made under Item Information: Results of Operations and Financial Condition, Item Information: Other Events, and Item Information: Financial Statements and Exhibits, although the content primarily relates to 'Other Events' regarding corporate contact details.
Filing Stats: 542 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2024-01-08 08:35:53
Key Financial Figures
- $0.01 — Registered Ordinary Shares, par value $0.01 per share PRTA The Nasdaq Global Se
- $621 million — s, and restricted cash of approximately $621 million as of December 31, 2023. This prelimina
Filing Documents
- d707357d8k.htm (8-K) — 26KB
- d707357dex991.htm (EX-99.1) — 23KB
- g707357g0106022700085.jpg (GRAPHIC) — 4KB
- 0001193125-24-003972.txt ( ) — 183KB
- prta-20240108.xsd (EX-101.SCH) — 3KB
- prta-20240108_lab.xml (EX-101.LAB) — 18KB
- prta-20240108_pre.xml (EX-101.PRE) — 11KB
- d707357d8k_htm.xml (XML) — 3KB
02
Item 2.02. Results of Operations and Financial Condition. In connection with the press release described in Item 8.01 below, on January 8, 2024, Prothena Corporation plc (the "Company") announced that it expects to report cash, cash equivalents, and restricted cash of approximately $621 million as of December 31, 2023. This preliminary estimate is based on currently available information and does not present all necessary information for a complete understanding of the Company's financial condition as of December 31, 2023, or the Company's results of operations for the fourth quarter or year-ended December 31, 2023.
01
Item 8.01. Other Events. On January 8, 2024, the Company issued a press release announcing certain business updates. A copy of that press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Financial Statements and Exhibits
Financial Statements and Exhibits (d) Exhibits . Exhibit No. Description 99.1 Press Release dated January 8, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 8, 2024 PROTHENA CORPORATION PLC By: /s/ Tran B. Nguyen Name: Tran B. Nguyen Title: Chief Strategy Officer and Chief Financial Officer